...
FDA Moves to Improve Safety and Efficacy of Sunscreen Products
October 3, 2021

The FDA on Sept. 27 released recommended revisions and updates to a proposed order concerning maximum sun protection factor (SPF) values, active ingredients, product labeling and other issues associated with over-the-counter sunscreens. A statement released by the agency characterizes the proposed updates as “substantially the same” as the 2019 proposed order written to ensure sunscreens are

...
Elevated prevalence of mental health problems in patients with skin cancer
May 6, 2020

Skin cancer is the most common tumor in humans.  The most common types of skin cancer are basal cell cancer, squamous cell cancer and melanoma skin cancer. Basal cell and squamous cell cancers are also termed non-melanoma skin cancers and keratinocyte cancers.  The main cause for skin cancer development is sun exposure, including both intermittent

...
Vitamin D deficiency is associated with higher mortality in melanoma patients
March 3, 2020

There has been quite a bit of news regarding Vitamin D in the medical literature over the  last several years. Numerous studies have highlighted a correlation among Vitamin D deficient patients and higher rates of cancers, including breast, colorectal, bladder and prostate cancer. Vitamin D is a hormone synthesized by ultraviolet radiation in the skin. 

...
Nicotinamide for skin cancer chemoprevention
February 1, 2020

Many providers who see skin cancers patients regularly have educated their patients regarding the ONTRAC skin cancer chemoprevention trial. This trial revealed patients with a history of keratinocytic cancers and actinic keratoses, who took Nicotinamide, 500 mg, twice daily, had a significantly decreased rate of the development of further keratinocytic cancers and actinic keratoses when

...
Transplant Dermatology
November 21, 2019

Faculty: Lindsay S. Ackerman, MD Thursday morning at the SDPA Fall Conference began with an enlightening lecture on skin cancer in solid organ transplant patients. Dr. Lindsay Ackerman described the solid organ transplant patient as the “most vulnerable population” for morbidity and mortality from the skin cancer epidemic. For example, transplant patients have a 65-fold